Explore national- and state-level data for hundreds of health, environmental and socioeconomic measures, including background information about each measure. Use features on this page to find measures; view subpopulations, trends and rankings; and download and share content.
How to use this page
United States Value:
Percentage of women ages 18-49 who reported misusing prescription psychotherapeutics (pain relievers, tranquilizers, stimulants or sedatives) or using cocaine (including crack), heroin, hallucinogens, inhalants or methamphetamine in the past year
Additional Measures:
Appears In:
Percentage of women ages 18-49 who reported misusing prescription psychotherapeutics (pain relievers, tranquilizers, stimulants or sedatives) or using cocaine (including crack), heroin, hallucinogens, inhalants or methamphetamine in the past year
Percentage of women ages 18-49 who reported misusing prescription psychotherapeutics (pain relievers, tranquilizers, stimulants or sedatives) or using cocaine (including crack), heroin, hallucinogens, inhalants or methamphetamine in the past year
Percentage of women ages 18-49 who reported misusing prescription psychotherapeutics (pain relievers, tranquilizers, stimulants or sedatives) or using cocaine (including crack), heroin, hallucinogens, inhalants or methamphetamine in the past year
SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health
Percentage of women ages 18-49 who reported misusing prescription psychotherapeutics (pain relievers, tranquilizers, stimulants or sedatives) or using cocaine (including crack), heroin, hallucinogens, inhalants or methamphetamine in the past year
SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health
US Value: 10.8%
Top State(s): Minnesota, Texas: 7.9%
Bottom State(s): Colorado: 18.7%
Definition: Percentage of women ages 18-49 who reported misusing prescription psychotherapeutics (pain relievers, tranquilizers, stimulants or sedatives) or using cocaine (including crack), heroin, hallucinogens, inhalants or methamphetamine in the past year
Data Source and Years: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019-2020
Suggested Citation: America's Health Rankings analysis of SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, United Health Foundation, AmericasHealthRankings.org, accessed 2023.
The use of illicit drugs, including prescription drugs without a doctor's guidance, can be dangerous and have lasting consequences. The Centers for Disease Control and Prevention (CDC) estimates that over 2 million people of all age groups were seen in emergency departments for non-fatal poisonings in 2020. During the same year, there were more than 91,000 drug overdose deaths in the United States, more than 28,000 of which were women.
Short-term effects of drug misuse include heart attack, stroke, psychosis and death. Long-term risks to health include contracting infectious diseases like HIV, hepatitis and heart infections, or developing medical conditions such as heart disease and certain cancers. Substance abuse can also lead to addiction, which often requires lifelong management. Drug use during pregnancy and breastfeeding has become more prevalent in the last decade and may increase the risk of miscarriage and stillbirth.
Mental health and substance use disorders are frequently related, though one can rarely be said to cause the other. Twenty percent of individuals with a severe mental health disorder will develop a substance use disorder during their lifetime. Experiencing intimate partner violence is associated with a higher risk of substance use. The health consequences of using illicit drugs are costly to both individuals and society. In 2007, the cost of illicit drug use to the U.S. was estimated at $193 billion. Emergency room visits for drug misuse among those ages 18-34 have increased from 45.4 visits per 10,000 people in 2009 to 76 visits per 10,000 in 2017.
The prevalence of illicit drug use is higher among:
Non-medical drug use can be prevented and treated. The National Institute on Drug Abuse lists 16 principles for choosing and implementing substance abuse prevention programs.
When prevention is no longer an option, there are evidence-based treatment programs. The Treatment Locator by the Substance Abuse and Mental Health Services Administration (SAMHSA) can help individuals find state-licensed providers that specialize in substance use disorders. SAMHSA also provides evidence-based resources for treatment facilities or medical practitioners that provide substance abuse treatment and recovery.
Healthy People 2030 objectives related to illicit drug use include:
Haight, Sarah C., Jean Y. Ko, Van T. Tong, Michele K. Bohm, and William M. Callaghan. “Opioid Use Disorder Documented at Delivery Hospitalization — United States, 1999–2014.” MMWR. Morbidity and Mortality Weekly Report 67, no. 31 (August 10, 2018): 845–49. https://doi.org/10.15585/mmwr.mm6731a1.
National Drug Intelligence Center. “National Drug Threat Assessment 2011.” Department of Justice, August 2011. https://www.justice.gov/archive/ndic/pubs44/44849/44849p.pdf.
Priester, Mary Ann, Teri Browne, Aidyn Iachini, Stephanie Clone, Dana DeHart, and Kristen D. Seay. “Treatment Access Barriers and Disparities Among Individuals with Co-Occurring Mental Health and Substance Use Disorders: An Integrative Literature Review.” Journal of Substance Abuse Treatment 61 (February 1, 2016): 47–59. https://doi.org/10.1016/j.jsat.2015.09.006.
“QuickStats: Number of Emergency Department Visits for Substance Abuse or Dependence per 10,000 Persons Aged ≥18 Years, by Age Group — United States, 2008–2009 and 2016–2017.” MMWR. Morbidity and Mortality Weekly Report 68, no. 50 (December 20, 2019): 1171. https://doi.org/10.15585/mmwr.mm6850a7.
Sachdeva, Punam, B. G. Patel, and B. K. Patel. “Drug Use in Pregnancy; a Point to Ponder!” Indian Journal of Pharmaceutical Sciences 71, no. 1 (2009): 1–7. https://doi.org/10.4103/0250-474X.51941.
Stone, Rebecca. “Pregnant Women and Substance Use: Fear, Stigma, and Barriers to Care.” Health & Justice 3, no. 1 (December 2015): 1–15. https://doi.org/10.1186/s40352-015-0015-5.
Varner, Michael W., Robert M. Silver, Carol J. Rowland Hogue, Marian Willinger, Corette B. Parker, Vanessa R. Thorsten, Robert L. Goldenberg, et al. “Association Between Stillbirth and Illicit Drug Use and Smoking During Pregnancy.” Obstetrics & Gynecology 123, no. 1 (January 2014): 113–25. https://doi.org/10.1097/AOG.0000000000000052.
America’s Health Rankings builds on the work of the United Health Foundation to draw attention to public health and better understand the health of various populations. Our platform provides relevant information that policymakers, public health officials, advocates and leaders can use to effect change in their communities.
We have developed detailed analyses on the health of key populations in the country, including women and children, seniors and those who have served in the U.S. Armed Forces, in addition to a deep dive into health disparities across the country.